http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9950033-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63d04b3d39cc851da8f74a2d2adf14fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2da8f5b60a60cbe6c18d6383ea3d292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35e38db230cc5450a4bd956b36620e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8dd08331fed0d577e972cd3f2989457
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b36fc440e2d62e826434977a569a0e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5df692884d2551802dd39bed4c4a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a71d875f51ffbec2b98e4255ff0a669
publicationDate 2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9950033-B2
titleOfInvention Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons
abstract The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10342851-B2
priorityDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8575105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007099227-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011294739-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450337570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161406

Total number of triples: 42.